Skip to content
10-Q

Quarterly Report

TAMIR BIOTECHNOLOGY, INC.

0001308411-13-000125

← back to feed
Filed
May 7, 2013 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 7, 2013 217.36M sh
Shares Diluted Q1 2013 · Oct 31, 2012 80.08M sh
Shares Diluted Q1 2013 · Oct 31, 2011 73.67M sh
Capex Q1 2013 · Oct 31, 2012 $0
Capex Q1 2013 · Oct 31, 2011 $0
Operating Cash Flow Q1 2013 · Oct 31, 2012 −$48.2K
Operating Cash Flow Q1 2013 · Oct 31, 2011 −$207.74K
Cash And Equivalents Q1 2013 · Oct 31, 2012 $5.85K
Cash And Equivalents Q1 2013 · Oct 30, 2012 $5.85K
Cash And Equivalents Q1 2013 · Jul 31, 2012 $24.04K
Cash And Equivalents Q1 2013 · Oct 31, 2011 $146.46K
Cash And Equivalents Q1 2013 · Jul 31, 2011 $354.2K
Eps Diluted Q1 2013 · Oct 31, 2012 −$0.01
Eps Diluted Q1 2013 · Oct 31, 2011 $0.00
Eps Basic Q1 2013 · Oct 31, 2012 −$0.01
Eps Basic Q1 2013 · Oct 31, 2011 $0.04
Sga Expense Q1 2013 · Oct 31, 2012 $99.45K
Sga Expense Q1 2013 · Oct 31, 2011 $122.94K
Rd Expense Q1 2013 · Oct 31, 2012 $50.25K
Rd Expense Q1 2013 · Oct 31, 2011 $70.57K
Net Income Q1 2013 · Oct 31, 2012 −$373.82K
Net Income Q1 2013 · Oct 31, 2011 $1.81M
Operating Income Q1 2013 · Oct 31, 2012 −$149.71K
Operating Income Q1 2013 · Oct 31, 2011 −$193.51K
Revenue Q1 2013 · Oct 31, 2012 $0
Revenue Q1 2013 · Oct 31, 2011 $0
Stockholders Equity Q1 2013 · Oct 30, 2012 −$6.4M
Stockholders Equity Q1 2013 · Jul 31, 2012 −$6.08M
Current Liabilities Q1 2013 · Oct 30, 2012 $5.76M
Current Liabilities Q1 2013 · Jul 31, 2012 $5.48M
Total Liabilities Q1 2013 · Oct 30, 2012 $6.43M
Total Liabilities Q1 2013 · Jul 31, 2012 $6.16M
Current Assets Q1 2013 · Oct 30, 2012 $17.23K
Current Assets Q1 2013 · Jul 31, 2012 $45.17K
Total Assets Q1 2013 · Oct 30, 2012 $29.85K
Total Assets Q1 2013 · Jul 31, 2012 $79.86K